Cipla, Ranbaxy and Biocon adopt Cirrius PharmaCRM platform on Microsoft Azure

For enabling multi-channel digitization of medical engagements Cirrius PharmaCRM Digital Platform on Microsoft Azure has been adopted by pharmaceutical companies such as Cipla , Ranbaxy and Biocon.

The platform comprises of three components, the base CRM platform, Closed Loop Marketing and the Phyzii engagement platform that fuels effective interactions between pharmaceutical companies and their network of medical reps, physicians, patients and the supply chain. Due to which subscribers of the Cirrius PharmaCRM Digital Platform see a digital transformation in their engagements.

“At Cirrius, we are digital transformation enablers to pharma companies top help them improve their engagements with their reps, physicians and patients by using our PharmaCRM platform and creative digital content creation. The platform agnostic and open capabilities of Azure allow us to focus on strengthening the content and quality of stakeholder engagement while rendering across devices and platforms is facilitated by Azure.The analytics capabilities in Azure further help us derive meaningful insights”, said Kapil Kuwelker, founder and CEO, Cirrius Technologies.

Srikanth Karnakota, director – Server and Cloud Business, Microsoft India said, “The Cirrius platform leverages Microsoft Azure to empower the pharma sales force and make their lives simpler. The platform underscores Microsoft’s commitment to consistently evolve and deliver quality solutions using technology to our customers. We are pleased with the way Cirrius is leveraging Microsoft Azure to bring the pharma companies closer to physicians and helping them stay up to date with the latest cloud technology.”